Phase II study of pirarubicin in untreated metastatic small cell lung carcinoma. Groupe Français de Pneumo-Cancérologie (GFPC)

Eur J Cancer. 1991;27(7):943. doi: 10.1016/0277-5379(91)90156-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / secondary
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Drug Evaluation
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary

Substances

  • Doxorubicin
  • pirarubicin